Summary
- Current Price
- As of today, GLUE price is $10.63, down -1.21% in the most recent trading session on
- Current Price All-Time High
- GLUE price is currently -76.67% below its historical high of $45.56 set on
- Market Cap
- GLUE current market cap is $907M, up +21.60% over the past 365 days
- Revenue
- GLUE current annual revenue is $123.67M, up +63.54% year-over-year
- Next Earnings
- The next earnings release for GLUE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Monte Rosa Therapeutics, Inc. |
| Ticker | NASDAQ: GLUE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | monterosatx.com |
| Employees | 142 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $10.63 | |
| Price, 1D Change | -1.21% | |
| $907M | ||
| - | ||
| - | ||
| 0.98 | ||
| $123.67M | ||
| Revenue, 1Y Change | +63.54% | |
| -$0.47 | ||
| EPS, 1Y Change | +52.72% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.47 | ||
| EPS Estimate | -$1.37 | N/A |
| EPS Est. Change | -195.66% | N/A |
| $123.67M | ||
| Revenue Estimate | $72.51M | N/A |
| Revenue Est. Change | -41.37% | N/A |
| Current Price | $10.63 | |
| Price Target | $27.00 | - |
| Price Tgt. Change | +154.00% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.21 | -$0.98 | +18.84% | |
| -$0.22 | -$0.47 | -113.30% | |
| -$1.37 | N/A | -195.66% | |
| -$1.84 | N/A | -296.71% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $59.78M | $75.62M | +26.51% | |
| $136.47M | $123.67M | -9.37% | |
| $72.51M | N/A | -41.37% | |
| $64.61M | N/A | -47.76% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $10.63 | |
| $17.31 | ||
| $12.00 | ||
| $15.08 | ||
| $12.30 | ||
| -$0.35 | ||
| 0.98 | ||
| $0.61 | ||
| 43.16 | ||
| 44.65% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $123.67M | ||
| -$0.47 | ||
| $115.32M | ||
| 93.24% | ||
| -$54.21M | ||
| -43.83% | ||
| -$38.63M | ||
| -31.23% | ||
| -$45.85M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.17 | ||
| 6.12 | ||
| 6.12 | ||
| - | ||
| 3 | ||
| 1.79 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 31.57 | ||
| 1.86 | ||
| -1.86 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $233.06M | ||
| $377.10M | ||
| $448.66M | ||
| $393.19M | ||
| $215.60M | ||
| $64.21M | ||
| $39.19M | ||
| $4.40M | ||
| $3.55M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $162.30M | ||
| $169.52M | ||
| $8.36M | ||
| $0.00 | ||
| $8.36M | ||
| $0.00 | ||
| -$1.10M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$22.80M | ||
| -$101.83M | ||
| $30.35M | ||
| $4.70M | ||
| -$27.50M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| Wedbush | → | |
| Guggenheim | → | |
| Wells Fargo | → | |
| JP Morgan | → | |
| Guggenheim | → | |
| Wedbush | → | |
| Guggenheim | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
No data
Screeners with GLUE
FAQ
- What is the ticker symbol for Monte Rosa Therapeutics, Inc.?
- The ticker symbol for Monte Rosa Therapeutics, Inc. is NASDAQ:GLUE
- Does Monte Rosa Therapeutics, Inc. pay dividends?
- No, Monte Rosa Therapeutics, Inc. does not pay dividends
- What sector is Monte Rosa Therapeutics, Inc. in?
- Monte Rosa Therapeutics, Inc. is in the Healthcare sector
- What industry is Monte Rosa Therapeutics, Inc. in?
- Monte Rosa Therapeutics, Inc. is in the Biotechnology industry
- What country is Monte Rosa Therapeutics, Inc. based in?
- Monte Rosa Therapeutics, Inc. is headquartered in United States
- When did Monte Rosa Therapeutics, Inc. go public?
- Monte Rosa Therapeutics, Inc. initial public offering (IPO) was on June 24, 2021
- Is Monte Rosa Therapeutics, Inc. in the S&P 500?
- No, Monte Rosa Therapeutics, Inc. is not included in the S&P 500 index
- Is Monte Rosa Therapeutics, Inc. in the NASDAQ 100?
- No, Monte Rosa Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Monte Rosa Therapeutics, Inc. in the Dow Jones?
- No, Monte Rosa Therapeutics, Inc. is not included in the Dow Jones index
- When was Monte Rosa Therapeutics, Inc. last earnings report?
- Monte Rosa Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Monte Rosa Therapeutics, Inc. report earnings?
- The next expected earnings date for Monte Rosa Therapeutics, Inc. is November 5, 2026
Data Sources & References
- GLUE Official Website www.monterosatx.com
- GLUE Profile on Yahoo Finance finance.yahoo.com/quote/GLUE
- GLUE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/glue